Literature DB >> 21423001

Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock.

Taka-aki Nakada1, James A Russell, John H Boyd, Luke McLaughlin, Emiri Nakada, Simone A Thair, Hiroyuki Hirasawa, Shigeto Oda, Keith R Walley.   

Abstract

OBJECTIVE: Angiotensin II and its postreceptor signaling are crucial in regulating vasomotor tone. The objective of this study was to test the hypothesis that single nucleotide polymorphisms in angiotensin II pathway genes alter outcome of septic shock.
DESIGN: Genetic association study and in vitro experiment.
SETTING: Intensive care units at academic teaching centers. PATIENTS: Derivation and validation septic shock cohorts (n = 589 and n = 616, respectively) and a coronary artery bypass surgery cohort (n = 551).
INTERVENTIONS: Patients with septic shock in the derivation cohort were genotyped for tag single nucleotide polymorphisms: angiotensin-converting enzyme (six single nucleotide polymorphisms), angiotensin II receptor type 1 (five single nucleotide polymorphisms), and angiotensin II type 1 receptor-associated protein (three single nucleotide polymorphisms), which is a negative regulator of angiotensin II receptor type 1. Patients in the septic shock replication cohort and the coronary artery bypass graft cohort were genotyped for the angiotensin II type 1 receptor-associated protein rs11121816.
MEASUREMENTS AND MAIN RESULTS: The primary outcome variable was 28-day mortality. Secondary outcome variables were blood pressure and heart rate. Angiotensin II type 1 receptor-associated protein messenger RNA expression was measured in genotyped lymphoblastoid cells in vitro. Patients with septic shock patients the GG genotype of angiotensin II type 1 receptor-associated protein rs11121816 had increased 28-day mortality in the derivation cohort (54.8% vs. 41.4%; adjusted hazard ratio, 1.46; 95% confidence interval, 1.09-1.93; p = .010 [all ethnicities]; p = .050 [white]) and in the replication cohort (43.8% vs. 32.3%; hazard ratio, 1.42; 95% confidence interval, 1.03-1.98; p = .035 [all ethnicities]; p = .037 [white]). Patients having the GG genotype had decreased mean arterial pressure (98.3% of other genotype, p = .058 [derivation cohort]; 97.7%, p = .00060 [replication cohort]) and increased heart rate (104.1%, p = .023 [derivation cohort], 102.9%, p = nonsignificant [replication cohort]). GG genotype patients undergoing coronary artery bypass grafting had decreased postoperative mean arterial pressure and increased postoperative heart rate (p < .05). GG genotype lymphoblastoid cells had 2.0-fold higher angiotensin II type 1 receptor-associated protein messenger RNA expression (p < .05).
CONCLUSIONS: For angiotensin II type 1 receptor-associated protein, the negative regulator of angiotensin II receptor type 1, the GG genotype of rs11121816 was associated with increased angiotensin II type 1 receptor-associated protein expression, decreased blood pressure, and increased heart rate as well as increased 28-day mortality in septic shock.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21423001     DOI: 10.1097/CCM.0b013e318218665a

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  Obesity and postgastrectomy outcomes: large risks, fat chances, or no big deal?

Authors:  Roderich E Schwarz
Journal:  Gastric Cancer       Date:  2012-04       Impact factor: 7.370

Review 2.  Vasopressor therapy in critically ill patients with shock.

Authors:  James A Russell
Journal:  Intensive Care Med       Date:  2019-10-23       Impact factor: 17.440

3.  Phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) binds and transfers phosphatidic acid.

Authors:  Kathryn Garner; Alan N Hunt; Grielof Koster; Pentti Somerharju; Emily Groves; Michelle Li; Padinjat Raghu; Roman Holic; Shamshad Cockcroft
Journal:  J Biol Chem       Date:  2012-07-21       Impact factor: 5.157

Review 4.  Beyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndrome.

Authors:  Nuala J Meyer
Journal:  Clin Chest Med       Date:  2014-09-23       Impact factor: 2.878

Review 5.  Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.

Authors:  Anders Perner; Anthony C Gordon; Daniel De Backer; George Dimopoulos; James A Russell; Jeffrey Lipman; Jens-Ulrik Jensen; John Myburgh; Mervyn Singer; Rinaldo Bellomo; Timothy Walsh
Journal:  Intensive Care Med       Date:  2016-10-01       Impact factor: 17.440

6.  The effect of endogenous angiotensin II on alveolar fluid clearance in rats with acute lung injury.

Authors:  Jia Deng; Dao-Xin Wang; Wang Deng; Chang-Yi Li; Jin Tong
Journal:  Can Respir J       Date:  2012 Sep-Oct       Impact factor: 2.409

7.  Noncanonical Nuclear Factor Kappa B (NF-κB) Signaling and Potential for Therapeutics in Sepsis.

Authors:  Simone Thair; James A Russell
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 8.  Vasopressor Choice and Timing in Vasodilatory Shock.

Authors:  Patrick M Wieruszewski; Ashish K Khanna
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097

9.  Genetic susceptibility to non-necrotizing erysipelas/cellulitis.

Authors:  Katariina Hannula-Jouppi; Satu Massinen; Tuula Siljander; Siru Mäkelä; Katja Kivinen; Rasko Leinonen; Hong Jiao; Päivi Aitos; Matti Karppelin; Jaana Vuopio; Jaana Syrjänen; Juha Kere
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock.

Authors:  Nuala J Meyer; Jane F Ferguson; Rui Feng; Fan Wang; Parth N Patel; Mingyao Li; Chenyi Xue; Liming Qu; Yichuan Liu; John H Boyd; James A Russell; Jason D Christie; Keith R Walley; Muredach P Reilly
Journal:  Am J Respir Crit Care Med       Date:  2014-09-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.